Psoriasis Clinical Trials

Showing 421-440 of 478 trials

Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis

NCT00332332

The purpose of this study is to evaluate the use of etanercept (Enbrel®) in the treatment of psoriasis in patients for a period of up to 1 year.

Psoriasis

Amgen246 participantsStarted Mar 2006

COMPLETEDPHASE4

Moderate to Severe Plaque Psoriasis With Scalp Involvement

NCT00791765

The purpose of this study is to determine if etanercept is effective in the treatment of scalp involvement in moderate to severe plaque psoriasis.

Psoriasis

Amgen124 participantsStarted Oct 2008

COMPLETEDPHASE4

Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis

NCT01714544

The purpose of this study is to determine whether Cloderm Cream is effective for topical treatment of moderate psoriasis over 28 days.

Psoriasis

Promius Pharma, LLC60 participantsStarted Oct 2012

Cincinnati, Ohio, United States • Portland, Oregon, United States • Austin, Texas, United States +2 more locations

COMPLETED

An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria

NCT01557283

With the new reimbursement criteria, we want: To describe the average treatment duration of patients with Enbrel expressed as a number of weeks/year. To describe the number of patients who receive continuous treatment To describe the number of patients who receive intermittent treatment To describe the number of weeks off treatment

Plaque Psoriasis Patients

Pfizer140 participantsStarted Sep 2011

Leuven, Belgium

Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis

Moderate to Severe Plaque Psoriasis With Scalp Involvement

Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis

An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria

Related Searches

Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test

Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab

Impact of Literacy Level on Patient Education and Health Among People With Arthritis

The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients

Surveillance of Humira Injection in Korean Patients

The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

Cell Responses to IFN-gamma

Efficacy Study of Dietary Intervention and Weight Loss in Improving Psoriasis

Nicotinamide in the Treatment of Psoriasis

A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks

Web-based Support to Manage Arthritis Pain

Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care

An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis